Skip to main content
. 2022 Feb 9;16(2):e0010096. doi: 10.1371/journal.pntd.0010096

Fig 6. Reduction in microfilaremia 12 months after treatment by drug regimen.

Fig 6

Data included only from participants who were microfilaremic at baseline (N = 67 in DA arm, N = 54 in IDA arm). DA: diethylcarbamazine and albendazole; IDA: ivermectin, diethylcarbamazine and albendazole; Mf: microfilaremia.